secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aveanna Healthcare Holdings, Inc. (AVAH)
CIK:        0001832332
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0000950170-23-020776
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aveanna Q1 net loss $32M vs prior year net income; revenue up 3.5% to $466.4M
-----------------------------------------------------------------------------

- Net loss of $32.0M ($0.17 diluted loss) vs net income of $25.3M ($0.14 diluted EPS) in Q1 2022.
- Adjusted EBITDA fell 25% to $28.5M (6.1% of revenue) from $38.0M (8.4%) in Q1 2022.
- Revenue increased 3.5% to $466.4M, driven by Private Duty Services (+$22.8M) and Medical Solutions (+$3.6M), partially offset by Home Health & Hospice (-$10.5M).
- Company affirms previously issued 2023 guidance; cash of $34.4M and undrawn revolver capacity of $162M as of April 1, 2023.
- Free cash flow was $2.9M for Q1 2023; net cash from operations $7.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832332/000095017023020776/0000950170-23-020776-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832332/000095017023020776/avah-20230511.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-020776

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer